An FDA investigation uncovered unreported strokes, suicides, and thousands of delayed side-effect reports from the maker of Ozempic and Wegovy — raising new questions about the safety oversight of America's most popular drugs.
Original Source:
https://www.moneytalksnews.com/fda-novo-nordisk-failed-to-report-deaths-of-weight-loss-drug-patients/